Drugs / Standard Donor Plasma
last change Feb 2021 re-read 2 minutes ago

Standard Donor Plasma

Developed for
COVID-19

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT04344535 Comparator Apr 2020 → Jan 2021 COVID-19 Stony Brook University Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Standard Donor Plasma ClinicalTrials.gov intervention name — accepted as the source's own label NCT04344535